Ricardo Armisen

Ricardo Armisen

Universidad del Desarrollo

H-index: 26

Latin America-Chile

About Ricardo Armisen

Ricardo Armisen, With an exceptional h-index of 26 and a recent h-index of 19 (since 2020), a distinguished researcher at Universidad del Desarrollo, specializes in the field of RNA biology, Cancer, Functional Genomics, Precision Medicine, Molecular Diagnostics.

His recent articles reflect a diverse array of research interests and contributions to the field:

A Comprehensive Analysis of the Effect of A> I (G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer

Deciphering the genomic landscape of Chilean cancer: Unveiling driver pathway divergence, and novel germline and actionable somatic variants

Tumor genomic heterogeneity in non-small cell lung cancer (NSCLC) patients from Latin America

Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis

Abstract C018: Disparities in the access to non-small cell lung cancer´ s target therapies in Chile

The Mechanistic Link Between Oral Health and Immune Profile in Gastric Cancer

ADAR1 influences alternative splicing through an RNA editing independent mechanism

Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women

Ricardo Armisen Information

University

Position

Centro de Genetica y Genomica ICIM Facultad de Medicina Clínica Alemana

Citations(all)

2009

Citations(since 2020)

941

Cited By

1448

hIndex(all)

26

hIndex(since 2020)

19

i10Index(all)

41

i10Index(since 2020)

32

Email

University Profile Page

Universidad del Desarrollo

Google Scholar

View Google Scholar Profile

Ricardo Armisen Skills & Research Interests

RNA biology

Cancer

Functional Genomics

Precision Medicine

Molecular Diagnostics

Top articles of Ricardo Armisen

Title

Journal

Author(s)

Publication Date

A Comprehensive Analysis of the Effect of A> I (G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer

Biomedicines

Yanara A Bernal

Alejandro Blanco

Eduardo A Sagredo

Karen Oróstica

Ivan Alfaro

...

2024/3/25

Deciphering the genomic landscape of Chilean cancer: Unveiling driver pathway divergence, and novel germline and actionable somatic variants

Cancer Research

Evelin González

Jessica Toro

Alejandro Blanco

Camilo Tapia

Solange Rivas

...

2024/3/22

Tumor genomic heterogeneity in non-small cell lung cancer (NSCLC) patients from Latin America

Cancer Research

Javiera Garrido

Evelin González

Gonzalo Sepúlveda-Hermosilla

Matias Freire

Alejandro Blanco

...

2024/3/22

Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis

International Journal of Molecular Sciences

Camilo Tapia-Valladares

Guillermo Valenzuela

Evelin González

Ignacio Maureira

Jessica Toro

...

2024/4/25

Abstract C018: Disparities in the access to non-small cell lung cancer´ s target therapies in Chile

Solange V Rivas

Evelin González

Alejandro Blanco

Carolina Ibáñez

Alejandro Corvalán

...

2023/1/1

The Mechanistic Link Between Oral Health and Immune Profile in Gastric Cancer

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

MATÍAS MUÑOZ-MEDEL

MAURICIO P PINTO

MAURICIO SÁEZ

ROCÍO ARTIGAS

VERÓNICA VILLALOBOS

...

2023/11/1

ADAR1 influences alternative splicing through an RNA editing independent mechanism

Eduardo A Sagredo

Victor Karlström

Alejandro Blanco

Paloma Moraga

Aino I Jarvelin

...

2023

Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women

Frontiers in oncology

Liz Maria de Almeida

Sandra Cortes

Marta Vilensky

Olivia Valenzuela

Laura Cortes-Sanabria

...

2022/3/8

El cáncer de pulmón de células no pequeñas en la era de la medicina de precisión

Solange Rivas

Ricardo Armisén

2022/1/1

MET signaling pathways, resistance mechanisms, and opportunities for target therapies

Solange Rivas

Arnaldo Marín

Suraj Samtani

Evelin González-Feliú

Ricardo Armisén

2022/11/11

Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients

Journal of Translational Medicine

Karen Y Oróstica

Juan Saez-Hidalgo

Pamela R de Santiago

Solange Rivas

Sebastian Contreras

...

2022/8/18

Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells

Gene

Fernanda Morales

Paola Pérez

Julio C Tapia

Lorena Lobos-González

José Manuel Herranz

...

2022/4/20

The transcriptomic portrait of locally advanced breast cancer and its prognostic value in a multi-country cohort of Latin American patients

Frontiers in oncology

Andrea Sabina Llera

Eliana Saul Furquim Werneck Abdelhay

Nora Artagaveytia

Adrian Daneri-Navarro

Bettina Müller

...

2022/3/22

Concordance analysis of ALK gene fusion detection methods in patients with Non–Small-Cell Lung Cancer from Chile, Brazil, and Peru

The Journal of Molecular Diagnostics

Gonzalo Sepúlveda-Hermosilla

Matías Freire

Alejandro Blanco

Javier Cáceres

Rodrigo Lizana

...

2021/9/1

Molecular features of breast cancer involved in classification and prognosis of a multi-country Latin American cohort: The US-LACRN-MPBCS breast cancer cohort

Cancer Research

Andrea S Llera

Eliana Abdelhay

Osvaldo Podhajcer

Nora Artagaveytia

Adrián Daneri-Navarro

...

2021/7/1

NTRK genomic alterations in Latin-American cancer patients.

Daniel Carvajal

Claudio Salas

Katherine Marcelain

Francisco Perez

Solange Rivas

...

2021/5/20

171P An unwelcome guest: P. gingivalis intratumoral infection and immune evasion in gastric cancer

Annals of Oncology

IN Retamal

M Muñoz Medel

M Cáceres

K Cereceda

F Villarroel-Espíndola

...

2021/12/1

Major histocompatibility complex class I-related chain A (MICA) allelic variants associate with susceptibility and prognosis of gastric cancer

Frontiers in Immunology

Karen Toledo-Stuardo

Carolina H Ribeiro

Andrea Canals

Marcela Morales

Valentina Gárate

...

2021/3/31

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and …

BMC cancer

Miguel Cordova-Delgado

María Loreto Bravo

Elisa Cumsille

Charlotte N Hill

Matías Muñoz-Medel

...

2021/12

Validation of a NGS panel, with automated analysis, designed for detection of medically actionable tumor biomarkers for Latin America

medRxiv

Mauricio Salvo

Evelin González-Feliú

Jessica Toro

Iván Gallegos

Ignacio Maureira

...

2021/3/20

See List of Professors in Ricardo Armisen University(Universidad del Desarrollo)

Co-Authors

H-index: 92
Gerald Zamponi

Gerald Zamponi

University of Calgary

H-index: 42
Hannah Carter

Hannah Carter

University of California, San Diego

H-index: 42
Felipe Simon

Felipe Simon

Universidad Andrés Bello

H-index: 39
Olivier Harismendy

Olivier Harismendy

University of California, San Diego

H-index: 22
Jimena Alejandra Sierralta

Jimena Alejandra Sierralta

Universidad de Chile

H-index: 21
Ricardo Verdugo

Ricardo Verdugo

Universidad de Chile

academic-engine